Resources

Download Latest Agenda

See the latest session topics and industry leading speakers on the 1.5 day agenda, with AI Applications in R&D, Clinical Trials and Moving from the ‘Science of AI’ to ‘Using AI Tools in Pharma Science

How can biopharma companies meet the challenge of attracting AI talent?

Implementing AI technologies requires a team that can span experimental science and computation...

Interview: Henry Che, Gilead Sciences

2017 Summit Attendee Henry Che, Director of R&D Information Systems, Gilead Sciences talks about the progress he and his colleagues have made on the goals they set at the 2017 Summit...

Download 2018 Event Overview

The event overview is now available to download, it includes just some of the agenda highlights you can look forward to this year, featured speakers and the top reasons to attend.

The “Why”, “How” and “When” of AI in Pharmaceutical Innovation

Last year brought about new hope and even more hype around the idea of applying artificial intelligence (AI) for “revolutionizing” drug discovery...

AI Health Matters Newsletter

Sign up for the AI Health Matters Newsletter to receive all the latest news and developments from the AI in Biopharma movement straight to your inbox

Setting the Stage – AI Investment and Applications in the Life Sciences

There continues to be strong interest within the life science and healthcare industries on innovations that can yield new actionable insights and improve operational efficiencies. With a full spectrum of validated applications spanning multiple industries, AI promises to deliver new capabilities...

Qrativ Interview: Using AI for drug discovery without spending MORE billions

In an all-new podcast, Daniel Faggella talks to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm nference. Murali and Daniel discuss the surge of medical information...

How the value of data is upending traditional business models in oncology

It’s 1990: ten years before the initial sequencing of the Human Genome Project was completed. Only ten years after the first clinical use of the MRI and still more than a decade before the Health Insurance Portability and Accountability Act (HIPAA) would be enacted...